.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chubb
Cantor Fitzgerald
Queensland Health
Express Scripts
Medtronic
Mallinckrodt
QuintilesIMS
Fish and Richardson
Healthtrust

Generated: November 24, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: exenatide synthetic

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astrazeneca Ab
BYDUREON
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LP0310-6520-044 TRAY in 1 CARTON (0310-6520-04) > 1 KIT in 1 TRAY * .65 mL in 1 SYRINGE * .65 mL in 1 VIAL
Astrazeneca Ab
BYDUREON
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LP0310-6530-011 CARTRIDGE in 1 TRAY (0310-6530-01) > .65 mL in 1 CARTRIDGE
Astrazeneca Ab
BYDUREON
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LP0310-6530-041 TRAY in 1 CARTON (0310-6530-04) > 4 CARTRIDGE in 1 TRAY > .65 mL in 1 CARTRIDGE
Astrazeneca Ab
BYDUREON
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LP0310-6530-851 TRAY in 1 CARTON (0310-6530-85) > 1 CARTRIDGE in 1 TRAY > .65 mL in 1 CARTRIDGE
Astrazeneca Ab
BYDUREON
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAmylin Pharmaceuticals, LLC66780-219-044 TRAY in 1 CARTON (66780-219-04) > 1 KIT in 1 TRAY * .65 mL in 1 VIAL * .65 mL in 1 SYRINGE, GLASS (66780-221-01)
Astrazeneca Ab
BYDUREON
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAmylin Pharmaceuticals, LLC66780-226-011 KIT in 1 TRAY (66780-226-01) * .65 mL in 1 VIAL * .65 mL in 1 SYRINGE, GLASS (66780-221-01)
Astrazeneca Ab
BYDUREON PEN
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LP0310-6520-044 TRAY in 1 CARTON (0310-6520-04) > 1 KIT in 1 TRAY * .65 mL in 1 SYRINGE * .65 mL in 1 VIAL
Astrazeneca Ab
BYDUREON PEN
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LP0310-6530-011 CARTRIDGE in 1 TRAY (0310-6530-01) > .65 mL in 1 CARTRIDGE
Astrazeneca Ab
BYDUREON PEN
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LP0310-6530-041 TRAY in 1 CARTON (0310-6530-04) > 4 CARTRIDGE in 1 TRAY > .65 mL in 1 CARTRIDGE
Astrazeneca Ab
BYDUREON PEN
exenatide synthetic
FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LP0310-6530-851 TRAY in 1 CARTON (0310-6530-85) > 1 CARTRIDGE in 1 TRAY > .65 mL in 1 CARTRIDGE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Cipla
Merck
Chubb
McKesson
Deloitte
Cantor Fitzgerald
Chinese Patent Office
US Army
AstraZeneca

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot